Enzyme inhibition activities of Andrachne cardifolia muell

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 22, Issue 2, 2007, Pages 235-238

  Ahmad, Bashir ^a   Shah, S M Hassan ^a   Bashir, Shumaila ^a   Shah, Jehandar ^b  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b UNIVERSITY OF MALAKAND   (Pakistan)

Author keywords

Acetylcholinesterase; Andrachne cardifolia; Butyrylcholinesterase; Lipoxygenase

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETYLCHOLINESTERASE; ANDRACHNE CARDIFOLIA EXTRACT; BUTANOL; CHLOROFORM; CHOLINESTERASE; LIPOXYGENASE; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG; UREASE;

ANDRACHNE CARDIFOLIA; ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DRUG ISOLATION; ENZYME INHIBITION; EUPHORBIA; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SOLVENT EXTRACTION;

1-BUTANOL; ACETATES; CHLOROFORM; ENZYME INHIBITORS; EUPHORBIACEAE; METHANOL; PLANT EXTRACTS;

ANDRACHNE;

EID: 34247123638     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360601051258     Document Type: Article

References (23)

1. (1990) The pharmacological basis of therapeutics, p. 96.
2. Ernst, RL and Hay, JW (1994) The US economic and social costs of Alzheimer's disease revisited. Am J Public Health, 84, pp. 1261-1264.
3. (1987) Basic pathology, p. 747.
4. Farlow, M., Gracon, SI and Hershey, LA (1992) Controlled trial of tacrine in Alzheimer's disease. J Am Med Assoc, 268, pp. 2523-2529.
5. Knapp, MJ, Knopman, DS and Solomon, PRA (1994) 30 week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J Am Med Assoc, 271, pp. 985-991.
6. Canal, I. and Imbimbo, BP (1996) Clinical trials and therapeutics: Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Clin Pharmacol Therap, 15, pp. 49-59.
7. Imbimbo, BP, Martelli, P. and Troetel, WM (1999) Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease. Neurology, 52, pp. 700-708.
8. Schwaez, M., Glick, D., Loewensten, Y. and Soreq, H. (1995) Pharmacology, 67, p. 283.
9. Rask-Madsen, J., Bukhave, K., Laursen, LS and Lauritsen, K. (1992) 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. Agents Actions, pp. C37-C46.
10. Hisaki, R., Fujita, H., Saito, F. and Kanmatsuse, K. (2004) Lipoxygenase inhibition and protection of cardiovascular system. Nippon Rinsho, 62, pp. 187-192.
11. Gopalan, G. (1976) Medicinal plants of India, 1, p. 64. Indian Council of Medical Research, New Delhi
12. Derasari, HR and Khasa, JH (1966) Indian J Pharm, 28:9, p. 237.
13. Ikram, M. and Hussain, S Fazal (1983) Planta Med, 47, p. 191.
14. Mukharjee, KS, Bhattachcharjee, P., Mukharjee, RK and Ghosh, PK (1986) Phytochem., 25:11, pp. 2669-2670.
15. Mukharjee, KS and Bhattachcharjee, P. (1987) Phytochem., 26:5, pp. 1539-1540.
16. Ellman, GL, Courtney, KD, Andres Jr, V. and Featherstone, RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 7, pp. 88-95.
17. Tappel, AL (1962) Methods in enzymology, 5, pp. 539-542. Academic Press
18. Weatherburn, MW (1967) Phenol-hypochlorite reaction for the determination of the ammonia. Anal Chem, 39, pp. 971-974.
19. Kattak, SG, Gilani, SN and Ikram, M. (1985) J Ethnopharmacol, 14, pp. 45-51.
20. Ahmad, Bashir, Jan, Qasim, Nisar, Muhammad, Bashir, Shumaila and Chaudhary, M Iqbal (2003) Asian J Plant Sci, 2:15, pp. 1107-1111.
21. Ahmad, Bashir, Jan, Qasim and Mansoor, Ahmad (2004) Int Chem Pharm Med J, 1, pp. 55-62.
22. Ahmad, Bashir, Khan, Haroon, Bashir, Shumaila, Nisar, M. and Hassan, M. (2006) J Enz Inhib Med Chem, 21:4, pp. 449-452.
23. Ahmad, Waqar, Ahmad, Bashir, Iqbal, Zafar and Nisar, M. (2003) J Biol Sci, 3:11, p. 1046.